To really lower clinical trial costs, one of the biggest line item that can have an impact on the bottom line is patient recruitment. According to stats[1], 80% of trials are delayed due to patient recruitment issues and causes several billions of dollars to industry. Furthermore, different locations, countries have different accural rates and proper planning is required to select the right sites.<p>IMO, providing a dashboard of trial stats to pharma is helpful but it would not really cut down the majority of costs.<p>1. <a href="http://www.ciscrp.org/professional/facts_pat.html" rel="nofollow">http://www.ciscrp.org/professional/facts_pat.html</a>